For many years, treatment for chronic Hepatitis B was recommended only for patients with very high levels of virus in the blood or clear signs of liver inflammation. However, our understanding of hepatitis B has evolved significantly. Recent research has shown that even patients with moderate viral levels may still develop liver damage or liver cancer over time.
As a result, new international guidelines are gradually expanding the group of patients who may benefit from treatment.
If you have hepatitis B and were previously told that treatment was not necessary, it may be worthwhile to review your condition again with a specialist.
What Is the Goal of Hepatitis B Treatment?
Modern antiviral medications for hepatitis B do not usually eliminate the virus completely, but they are very effective at suppressing viral replication.
The goals of treatment are to:
- Reduce the amount of virus in the blood
- Prevent ongoing liver inflammation
- Slow or stop the progression of liver scarring (fibrosis)
- Reduce the risk of cirrhosis
- Lower the risk of liver cancer
By keeping the virus suppressed, treatment helps protect the liver over the long term.
Traditional Criteria for Treatment
Previously, treatment was typically recommended only when patients had:
- High viral loads (often above 20,000 IU/mL)
- Elevated liver enzymes indicating liver inflammation
- Evidence of liver damage or cirrhosis
Patients who did not meet these criteria were usually monitored without medication.
However, doctors began noticing that some patients with lower viral levels still developed complications over time.
Why Treatment Recommendations Are Changing
Large long-term studies have shown that the risk of liver cancer and liver disease does not suddenly appear only when viral levels become extremely high.
Instead, risk gradually increases as viral levels rise, even within ranges that were previously considered “low”.
This has led many experts to recommend earlier treatment in selected patients, particularly when additional risk factors are present.
Patients Who May Now Be Considered for Treatment
While treatment decisions are always individualized, current guidelines increasingly recommend considering antiviral therapy in patients with:
Persistent Viral Load Above 2,000 IU/mL
Even moderate levels of virus may contribute to long-term liver injury.
Evidence of Liver Fibrosis
If liver scans show early scarring, treatment may be recommended even if liver enzymes are normal.
Age Over 40–50 Years
The longer someone lives with hepatitis B, the greater the cumulative risk of complications.
Family History of Liver Cancer
Patients with relatives who developed liver cancer may benefit from earlier treatment.
Coexisting Liver Conditions
Conditions such as fatty liver disease or alcohol-related liver injury may increase the risk of progression.
Because of these factors, some patients who were previously observed without treatment may now qualify for therapy.
Modern Hepatitis B Medications
- The most commonly used antiviral medications today are highly effective and well tolerated.
- They work by blocking the virus from multiplying, allowing the liver to remain healthy.
- Most patients take one tablet daily, and serious side effects are uncommon.
- Treatment is often long-term, but it provides important protection against future liver complications.
Why Regular Monitoring Is Still Important
Even if treatment is not immediately required, patients with hepatitis B still need regular follow-up with a specialist.
This allows doctors to monitor:
- Viral load
- Liver enzyme levels
- Liver fibrosis
- Risk of liver cancer
Because hepatitis B can change over time, ongoing monitoring ensures that treatment can be started at the right time if needed.
When Should You Seek a Specialist Review?
You may benefit from a specialist consultation if:
- You were diagnosed with hepatitis B many years ago
- You have not had recent viral load testing
- You were previously told treatment was unnecessary
- You have a family history of liver cancer
- You want to understand whether new guidelines apply to you
A specialist assessment can help determine the best long-term strategy to protect your liver health.
Written by:
Dr Mark Fernandes
Gastroenterologist
Dr Mark Fernandes specialises in the diagnosis and management of digestive and liver diseases, including hepatitis B, fatty liver disease, cirrhosis, and liver cancer screening.
